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Abstract
Background: The amyloid precursor protein (APP) is transported via the secretory pathway to
the cell surface, where it may be cleaved within its ectodomain by α-secretase, or internalized
within clathrin-coated vesicles. An alternative proteolytic pathway occurs within the endocytic
compartment, where the sequential action of β- and γ-secretases generates the amyloid β protein
(Aβ). In this study, we investigated the effects of modulators of endocytosis on APP processing.
Results: Human embryonic kidney cells were transfected with a dominant negative mutant of
dynamin I, an important mediator of clathrin-dependent endocytosis, and APP proteolysis was
analyzed. Overexpression of the mutant dynamin (dyn I K44A) resulted in increased shedding of
the APP ectodomain (sAPPα), accumulation of the C-terminal α-secretase product C83, and a
reduction in the release of Aβ. Levels of mature APP on the cell surface were increased in cells
expressing dyn I K44A, and internalization of surface-immunolabeled APP, assessed by fluorescence
microscopy, was inhibited. Dynamin is a substrate for protein kinase C (PKC), and it was
hypothesized that activators of PKC, which are known to stimulate α-secretase-mediated cleavage
of APP, might exert their effects by inhibiting dynamin-dependent endocytosis. However, the
internalization of surface-biotinylated APP was unaffected by treatment of cells with phorbol 12-
myristate 13-acetate in the presence of the α-secretase inhibitor TAPI-1.
Conclusion: The results indicate that APP is internalized by a dynamin-dependent process, and
suggest that alterations in the activity of proteins that mediate endocytosis might lead to significant
changes in Aβ production.
Background
The amyloid precursor protein (APP) is a single-pass
transmembrane protein that gives rise to the small pep-
tides (known as Aβ) that form amyloid deposits in the
brains of patients with Alzheimer's disease (AD) [1,2]. Aβ
peptides are generated by the successive cleavage of APP
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by proteases known respectively as β- and γ-secretases.
Alternatively, APP may be cleaved within the Aβ domain
by α-secretases, now believed to be members of the disin-
tegrin and metalloprotease (ADAM) family [3-5]. This lat-
ter process precludes the formation of Aβ, and results in
the shedding of a large soluble N-terminal fragment of
APP (sAPPα) into the extracellular or intra-luminal space.
Cleavage of APP by α-secretases may occur in a late com-
partment of the secretory pathway, or at the cell surface
[6].
APP ectodomain shedding occurs in both a constitutive
and a regulated fashion. A key mediator of regulated shed-
ding is protein kinase C (PKC), whether it is stimulated
directly by phorbol esters, or as a consequence of the acti-
vation of receptors coupled to phosphoinositide turnover.
Although the stimulation of APP shedding by PKC activa-
tors has been extensively documented [7], the mechanism
is still unclear. Direct phosphorylation of the APP intrac-
ellular domain is not required, since phorbol esters are
still able to increase shedding of a C-terminally truncated
form of APP, or of APP constructs in which serine or thre-
onine residues in the cytoplasmic domain have been
replaced with alanine [8-10]. Likewise, C-terminal trunca-
tion of the putative α-secretase ADAM17/TACE (tumor
necrosis factor-α converting enzyme) did not prevent up-
regulation of its activity toward its substrate tumor necro-
sis factor-α (TNFα) by phorbol 12-myristate 13-acetate
(PMA) [11]. On the other hand, phorbol ester-regulated
cleavage of TrkA by TACE was found to be dependent, in
part, on phosphorylation of threonine 735 within the
TACE cytoplasmic domain [12]. Thus, phosphorylation of
ADAM proteases may modulate their activity, at least
toward certain substrates.
PKC-mediated effects on vesicular trafficking might also
affect APP processing. A study showing that PKC activa-
tion increases the formation of APP-containing secretory
vesicles from the trans-Golgi network [13], suggested that
accelerated trafficking of APP to the cell surface might
underlie the increase in sAPPα release induced by PKC.
Alternatively, inhibition of endocytosis could increase
sAPPα release by prolonging the interaction of APP with
secretases on the cell surface. APP is found within clath-
rin-coated vesicles [14,15], which mediate the internaliza-
tion of many cell surface proteins. Clathrin-dependent
endocytosis is regulated by the high-molecular weight
GTPase dynamin, which forms oligomeric rings around
the neck of the forming vesicle, and severs it from the
plasma membrane [16]. Dynamin activity, in turn, is
reportedly governed by PKC [17-19], raising the possibil-
ity that PKC might modulate internalization, and there-
fore secretory cleavage, of APP, via an effect on
endocytosis.
The aims of the present study were two-fold: to examine
the effects of an inhibitor of dynamin function on APP
processing, and to determine if PKC activation stimulates
APP shedding via inhibition of endocytosis. Overexpres-
sion of a dominant negative dynamin mutant in HEK cells
co-transfected with APP695 increased surface expression of
APP and release of sAPPα, while inhibiting the internali-
zation of full-length APP. The dynamin mutant also
increased formation of C83, the C-terminal stub gener-
ated by α-secretase-mediated cleavage of APP, and
reduced the release of Aβ peptides. These results contrast
with a recent study, in which induction of dominant neg-
ative dynamin (dyn I K44A) increased both sAPPα release
and Aβ formation [20]. Although activation of PKC by
treatment with the phorbol ester PMA stimulates shed-
ding of the APP ectodomain, PMA had no effect on the
internalization of surface-biotinylated APP. Our observa-
tions provide direct evidence that APP internalization is a
dynamin-dependent process. Moreover, the results indi-
cate that activators of PKC do not promote sAPPα release
via inhibition of endocytosis.
Results
Ectodomain shedding of APP is increased in cells 
transfected with dyn I K44A
The GTPase dynamin is an important mediator of clath-
rin-dependent endocytosis and synaptic vesicle recycling,
and is required for the internalization of many cell surface
proteins, including growth factor and G-protein coupled
receptors [21]. To determine if dynamin regulates the
internalization of APP, HEK-M3 cells were transiently
transfected with APP695 and either an empty vector or a
plasmid encoding the dominant-negative dynamin
mutant dyn I K44A, which is deficient in GTP binding and
GTPase activity [22]. The APP695 isoform was used for
these transfection studies, since it is not expressed by HEK
cells; and can be distinguished on western blots from the
longer endogenous APP isoforms. Cells transfected with
empty vectors alone were used as additional controls. Lev-
els of sAPPα in the medium, and cellular full-length APP,
were detected by western blotting using 6E10 antibodies,
and antibodies to the APP C-terminus (APP-CT), respec-
tively. The expression of endogenous dynamin, assessed
using an antibody that recognizes both dynamin I and
dynamin II isoforms, was low in cells transfected with
APP695 or empty vector, and robust overexpression of the
mutant protein was observed in cells transfected with the
plasmid encoding dyn I K44A (Fig. 1A, lower panel).
Dynamin I is neuron-specific, whereas dynamin II is
widely expressed. The immunoreactive band present in
cells that were not transfected with the dynamin plasmid
presumably represents dynamin II, since no signal was
detectable when lysates from these cells were immunob-
lotted with antibodies specific for dynamin I (not shown).
An increase of approximately five-fold in the release ofBMC Cell Biology 2005, 6:30 http://www.biomedcentral.com/1471-2121/6/30
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endogenous and transfected sAPPα from cells transfected
with dyn I K44A was observed (Fig. 1A, upper panel, and
Fig. 1B). Levels of cellular full-length APP were also
increased in cells expressing the dynamin mutant (Fig. 1A,
middle panel). Quantitation of the band comprising
mature cellular APP695 and immature endogenous APP
(APPendo) showed that levels in the presence of the mutant
dynamin increased to 2.86 ± 0.97-fold control levels
(mean ± SEM, n = 3). Overnight treatment of APP695 trans-
fectants with the lysosomal protease inhibitor chloro-
quine (50 µM) increased levels of this band to a similar
extent (to 2.30 ± 0.02-fold control, mean ± SEM from 3
experiments).
Inhibition of dynamin function increases surface 
expression of APP
The effect of the dynamin mutant on surface expression of
APP was next examined by surface biotinylation of tran-
siently transfected HEK-M3 cells. In cells transfected with
empty vector alone, one diffuse band of biotinylated APP
representing mature endogenous APP was visible on west-
ern blots (Fig. 2A, lanes 1 and 2). Cells transfected with
APP695 expressed an additional, more rapidly migrating
band, representing mature cell surface APP695 (Fig. 2A,
lanes 3 and 4). Surface expression of both endogenous
and transfected APP695 was greatly increased in cells over-
expressing dyn I K44A (Fig. 2A, lanes 5 and 6). As shown
in Fig. 1, both mature isoforms of APP were released into
the medium of APP695 transfectants, and release of both
Release of sAPPα is increased by dyn I K44A overexpression Figure 1
Release of sAPPα is increased by dyn I K44A overex-
pression. HEK-M3 cells were transiently transfected with 
APP695 and dyn I K44A or empty vector. After 48 hours, the 
growth medium was replaced with serum-free medium, and 
collected after 2 hours. Proteins in media extracts and cell 
lysates were size-fractionated on SDS gels and analyzed by 
immunoblotting. A. Expression of dyn I K44A increased 
release of endogenous and co-transfected sAPPα (upper 
panel; bands were detected with 6E10 antibodies) and levels 
of cellular APP (middle panel; bands were detected with anti-
APP-CT). Arrows indicate mature (m) and immature (im) 
isoforms of endogenous and transfected APP. The mutant 
dynamin was expressed at high levels in transfected cells 
(lower panel). The lanes depicted in each panel were derived 
from the same blot. B. Levels of sAPPα in the media extracts 
were quantitated by densitometry and values were 
expressed as means ± SEM from 3 experiments. *, signifi-
cantly different from the other two groups, by analysis of var-
iance and Fisher's Least Significant Difference test.
Surface expression of APP is increased by dyn I K44A  overexpression Figure 2
Surface expression of APP is increased by dyn I K44A 
overexpression. A. HEK-M3 cells were transiently trans-
fected with APP695 and dyn I K44A or empty vector. After 48 
hours, cells were surface biotinylated, lysed, and incubated 
with streptavidin-agarose beads. Biotinylated proteins were 
immunoblotted with antibodies to the APP C-terminal. Full-
length, biotinylated, endogenous and co-transfected APP are 
indicated by arrows. B. HEK-695 cells were transiently trans-
fected with dyn I K44A or empty vector. Immunoblot analy-
sis of cell lysates showed increased formation of the APP C-
terminal fragment (C83) generated by α-secretase cleavage 
in cells transfected with the dynamin mutant. C. Results from 
B were quantitated, normalized and expressed as means ± 
SEM from 3 experiments. *, p < 0.05 by paired t-test.BMC Cell Biology 2005, 6:30 http://www.biomedcentral.com/1471-2121/6/30
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isoforms was markedly increased in cells overexpressing
dyn I K44A.
Expression of dyn I K44A increases formation of the APP 
C-terminal fragment C83
Cleavage of APP by α-secretase results in the release of the
soluble ectodomain fragment sAPPα, and leaves a C-ter-
minal stub, known as C83, in the cell membrane. In HEK
cells stably overexpressing APP695 (HEK-695 cells) a pro-
tein corresponding in size to C83 was detected by western
blotting of cell lysates with antibodies to the APP C-termi-
nus (Fig. 2B). The corresponding β-secretase product C99
was not detectable under these conditions. Levels of C83
were significantly increased in cells transfected with dyn I
K44A, relative to levels in cells transfected with empty vec-
tor alone (Fig. 2B and 2C), consistent with the increase in
ectodomain shedding observed in cells expressing the
dynamin mutant.
Internalization of APP is inhibited in cells transfected with 
dyn I K44A
Our results can be interpreted to suggest that overexpres-
sion of dyn I K44A inhibits endocytosis of APP. The
increase in cellular levels of APP observed in cells express-
ing the mutant dynamin, accordingly, could be the result
of decreased internalization and degradation of full-
length APP (Fig. 1A), and indeed, the lysosomal protease
inhibitor chloroquine exerted a similar effect. However, it
could also be argued that the increases in APP surface
expression and shedding caused by the dynamin mutant
were secondary to elevations in APP expression. There-
fore, in order to directly examine the effect of dynamin on
APP endocytosis, APP internalization in living cells was
assessed using an immuno-labeling assay. Live HEK cells
stably overexpressing APP695 were incubated at 4°C with
6E10 antibodies, in order to label cell surface APP. The
cells were washed and warmed to 37°C for various
intervals, and then fixed, permeabilized, and stained with
Alexa 488-conjugated secondary antibodies. In cells that
were labeled on ice and then fixed and stained prior to
warming, APP was largely confined to the plasma mem-
brane (Fig. 3A, 0 min). After 10 minutes at 37°C, most of
the immunofluorescence was contained within intracellu-
lar punctuate structures distributed throughout the cyto-
plasm, indicating that surface APP had moved into an
endosomal compartment. By 60 minutes, the immun-
ofluorescent signal representing internalized APP had for
the most part coalesced at a perinuclear site (Fig. 3A).
Only background fluorescence was observed in cells that
were incubated with antibodies to paxillin, an intracellu-
lar protein (not shown). APP internalization was next
determined in these cells 48 hours after the cultures were
transiently transfected with dyn I K44A. The cells were sur-
face-labeled with 6E10 antibodies, and incubated at 37°C
for 10 minutes. They were then fixed, permeabilized, and
stained with Alexa 488-conjugated anti-mouse IgG to
detect APP. Dynamin I expression was assessed by co-
staining cells with goat anti-dynamin I antibodies fol-
lowed by Alexa 594-conjugated anti-goat IgG. Immunob-
lot analysis of cell lysates confirmed that this antibody,
which is specific for dynamin I, does not detect endog-
enous dynamin in non-transfected cells (not shown). In
cells expressing the mutant dynamin I (Fig. 3B, right
panel), APP immunoreactivity was restricted to the cell
surface (Fig. 3B, left panel), whereas untransfected cells
within the same culture exhibited a punctate pattern of
APP immunofluorescence indicative of internalization
(Fig. 3B, arrows). These results provide direct evidence
that dyn I K44A inhibits endocytosis of APP.
Overexpression of dyn I K44A inhibits the formation of Aβ 
peptides
In order to determine if dynamin inhibition affects the
formation of Aβ peptides, levels of Aβ1–40 in the medium
of HEK-695 cells transiently transfected with either an
empty vector or dyn I K44A were measured by ELISA.
Overexpression of the dynamin I mutant caused a signifi-
cant reduction in Aβ release (Fig. 4), suggesting that APP
internalization is necessary for generation of Aβ in HEK
cells.
Activation of PKC does not affect internalization of APP
Activation of PKC by administration of phorbol esters, or
via stimulation of receptors coupled to PKC, increases
APP ectodomain shedding, but the mechanism remains
unclear [7]. It is known that inhibiting APP endocytosis
via mutation of internalization motifs, or truncation of
the cytoplasmic domain, also increases ectodomain shed-
ding [23-25], raising the possibility that physiological
mechanisms that regulate shedding might act by targeting
the endocytic machinery. To address this question, the
effect of the PKC activator PMA on APP internalization in
HEK cells stably overexpressing APP695 was determined
using reversible surface biotinylation. Shedding was
inhibited by incubating cells with the α-secretase inhibi-
tor TAPI-1 for 1 hour prior to biotinylation. Cells were
surface-biotinylated while on ice, then incubated at 37°C
in DMEM containing TAPI-1 and either PMA (1 µM) or
the vehicle dimethylsulfoxide (DMSO) for varying peri-
ods of time. Media and cell lysates were collected and
processed as described (see "Methods"). As a control for
stripping efficiency, some cultures were biotinylated and
stripped while remaining on ice (Fig. 5A). Despite the
presence of TAPI-1, there was a slight, but detectable,
time-dependent increase of biotinylated sAPPα695 in the
medium. This was not affected by PMA, indicating that
TAPI-1 effectively blocked the signal-dependent release of
APP (Fig. 5B, upper panel). Levels of internalized bioti-
nylated APP declined over the 60 minute incubation
period, consistent with the degradation of internalizedBMC Cell Biology 2005, 6:30 http://www.biomedcentral.com/1471-2121/6/30
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APP, or the removal of the biotin label in an endocytic
compartment. APP internalization was not significantly
altered by the presence of PMA (Fig. 5B, middle panel,
and 5C). In the absence of TAPI-1, PMA caused a marked
increase in secretion of endogenous and transfected
sAPPα from HEK-695 cells, as expected (Fig. 5D).
Discussion
Cleavage of APP within the Aβ domain by α-secretases is
of great physiological interest, not only because it pre-
cludes the formation of Aβ, but also because it generates a
soluble N-terminal fragment, sAPPα, that exhibits neuro-
protective properties [26,27]. Moreover, shedding of the
ectodomain is a prerequisite for cleavage of the intracellu-
lar domain by γ-secretases; a process that liberates a C-ter-
minal fragment with transcriptional activity [28-30].
Although the up-regulation of APP shedding by activation
of PKC-dependent signaling pathways has been well-doc-
umented [7], the mechanism mediating this response is
still obscure.
APP internalization is inhibited in cells transfected with dyn I  K44A Figure 3
APP internalization is inhibited in cells transfected 
with dyn I K44A. A. HEK-695 cells were surface-immu-
nolabeled with 6E10 antibodies for 45 min while on ice. The 
cells were then incubated at 37°C for varying periods of 
time, to allow internalization to occur. Prior to warming (0 
min), APP immunofluorescence was confined to the cell 
membrane. Within 5 minutes APP immunoreactivity was 
located within punctate structures near the cell membrane. 
By 60 minutes, most of the immunoreactivity had coalesced 
at a perinuclear site. B. HEK-695 cells were transiently trans-
fected with dyn I K44A. After 48 hours, cells were surface-
labeled with 6E10 antibodies, then incubated at 37° for 10 
min. In untransfected cells (arrows) APP (green) was inter-
nalized within intracellular vesicles within 10 minutes. In dyn I 
K44A-transfected cells (red), APP immunoreactivity was still 
largely membrane-associated at this time-point, indicating 
that internalization was impaired in cells expressing the 
dynamin mutant. Bar, 10 µm.
Dyn I K44A inhibits Aβ formation Figure 4
Dyn I K44A inhibits Aβ formation. HEK-695 cells were 
transiently transfected with empty vector or dyn I K44A. 
Medium was collected for 24 hours and analyzed for Aβ1–40 
levels by sandwich ELISA. Levels of Aβ1–40 were significantly 
lower in the medium of cells transfected with dyn I K44A. *, 
p < 0.05 by paired t-test.BMC Cell Biology 2005, 6:30 http://www.biomedcentral.com/1471-2121/6/30
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The present study was undertaken to determine if inhibi-
tors of dynamin function would affect ectodomain shed-
ding of APP. We first showed that APP internalization is
dependent on the activity of dynamin, a large molecular
weight GTPase that mediates both clathrin-dependent
endocytosis, and internalization of caveolae, by promot-
ing the separation of endocytic vesicles from the plasma
membrane [22,31]. In confirmation of a recent study [20],
we found that overexpression of a dominant negative
dynamin mutant protein in HEK cells increased surface
Activation of PKC does not affect APP internalization Figure 5
Activation of PKC does not affect APP internalization. HEK-695 cells were pre-treated with TAPI-1 in serum free 
DMEM for 1 hour prior to biotinylation. After biotinylation and quenching, cells were incubated at 37°C for various time peri-
ods in the presence of TAPI-1 and either DMSO or PMA (1 µM). The medium was collected and biotinylated sAPPα was iso-
lated and analyzed by immunoblot using 6E10 antibodies. The cells were stripped and lysed, and biotinylated APP was isolated 
and assessed by immunoblot analysis with antibodies to the APP C-terminal. A. Internalization of biotinylated APP was nearly 
absent in cells that were biotinylated and stripped (B/S) while still on ice. NB, non-biotinylated; B, biotinylated, not stripped. B. 
PMA, in the presence of TAPI-1, did not affect release of biotinylated sAPPα(upper panel), or internalization of full-length bioti-
nylated APP (middle panel). C. Bands depicting biotinylated and internalized APP were quantitated by densitometry, normal-
ized, and expressed as means ± SEM from 3 experiments. D. In the absence of TAPI-1, PMA caused a marked increase in 
release of endogenous and transfected sAPPα from HEK-695 cells.BMC Cell Biology 2005, 6:30 http://www.biomedcentral.com/1471-2121/6/30
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expression of full-length APP, and release of sAPPα. Thus,
although cleavage of APP by α-secretases occurs largely in
an intracellular compartment in many cell types
(reviewed in [6]), our results suggest that inhibition of
dynamin function, by preventing internalization of APP,
increases its dwell-time on the cell surface, and prolongs
its interaction with α-secretases at the plasma membrane.
Similar elevations in APP secretion are induced by muta-
tions of the APP cytoplasmic domain that inhibit internal-
ization [23-25]. Consistent with the observed increase in
α-secretase mediated cleavage, expression of the dynamin
mutant increased cellular levels of C83, the C-terminal
stub remaining after α-secretase-mediated cleavage of APP
(Fig. 2B and 2C).
The increase in sAPPα release in HEK cells overexpressing
dyn I K44A was associated with a reduction in the release
of Aβ1–40, (Fig. 4), a result in keeping with reports that Aβ
is generated in an endocytic compartment [24,25,32-34].
Our results are also in agreement with a study by Ehehalt
et al. [35] who found that overexpression of a dyn K44A
mutant protein reduced formation of the Aβ peptide in
mouse neuroblastoma N2a cells. In contrast, Chyung and
Selkoe reported that Aβ generation was increased in HeLa
cells following induction of dyn K44A expression [20].
The increased Aβ formation observed in the latter study
occurred in the absence of any alteration in the synthesis
or maturation of APP, and suggested that, in HeLa cells,
processing of APP by β- and γ-secretases occurs at the
plasma membrane [20]. Indeed, an active γ-secretase com-
plex was subsequently isolated from the plasma mem-
brane of HeLa cells [36]. As a possible explanation for the
reduction in Aβ observed by Ehehalt et al. [35] in cells
overexpressing dyn K44A, Chyung and Selkoe pointed out
that those workers measured formation of radiolabeled
Aβ in cells labeled for 1 hour with [35S]methionine, and
surmised that the mutant dynamin reduced generation of
labeled Aβ by increasing the amount of unlabeled APP at
the cell surface, and diluting the concentration of labeled
precursor available for cleavage by β- and γ-secretases. In
support of the notion that Aβ can be generated at the cell
surface, Ehehalt et al [35] showed that when endocytosis
was blocked by transfection with dyn K44A, the reduction
in Aβ could be partially rescued by antibody cross-linking
of APP and the β-secretase, β-site APP-cleaving enzyme
(BACE). The decrease in total Aβ1–40 generation in HEK
cells overexpressing dyn I K44A described in the present
report might simply reflect reductions in the precursor
pool due to increased cleavage of APP by α-secretase. This
result is consistent with earlier studies showing that
upregulation of α-secretase cleavage by PKC activation in
HEK cells [37], or via mutations of the APP cytoplasmic
domain in stably transfected HEK or Chinese hamster
ovary (CHO) cells [23-25], is associated with decreased
Aβ formation. The discrepancies among these studies
might be due at least in part to cell-specific differences in
the compartments where APP comes into contact with α-
and  β/γ-secretases, or in the relative capacities of the
different secretases to cleave APP within a specific
compartment.
Modulation of endocytosis might represent a mechanism
for physiological regulation of APP processing by PKC-
dependent signaling pathways. PKC phosphorylates
dynamin, thereby activating its GTPase activity [17], and
inhibiting its association with phospholipids in vitro [18].
In nerve terminals, dynamin must be dephosphorylated
in order to promote retrieval of synaptic vesicles following
exocytosis, and re-phosphorylation is required for the
next round of endocytosis that follows a second stimulus
[19]. Persistent phosphorylation of dynamin might there-
fore be predicted to interfere with endocytosis. Contrary
to expectation, the PKC activator PMA did not affect the
rate of APP internalization, as determined by reversible
biotinylation in the presence of the α-secretase inhibitor
TAPI-1 (Fig. 5). Thus, although PKC activation can modu-
late endocytosis of a variety of transmembrane proteins,
either positively, in the case of β1 integrin, GABA recep-
tors, and the dopamine transporter [38-41], or negatively,
as is the case with µ-opioid receptors [42], we could not
find evidence for a modulatory effect of phorbol esters on
APP internalization. Others have shown that PKC activa-
tion increases APP ectodomain shedding in PC12 cells by
stimulating trafficking of APP through the secretory path-
way [13]. In contrast, surface expression of APP was
reduced in CHO cells that were surface biotinylated fol-
lowing treatment with PMA and TAPI, suggesting that in
these cells, PMA did not increase trafficking of APP to the
plasma membrane, but possibly stimulated α-secretase-
mediated cleavage within an intracellular compartment
that was partially resistant to TAPI [43]. Interestingly, the
motor neuron-derived trophic factor neuregulin-1, a lig-
and for the tyrosine kinase receptors ErbB3 and ErbB4,
was found to increase the rate of internalization and
degradation of APP in cultured myotubes, while decreas-
ing release of the ectodomain [44]. This report lends cre-
dence to the hypothesis that modulation of APP
internalization may represent a physiological mechanism
for regulation of sAPPα release.
Conclusion
Our results show that experimental manipulations that
interfere with the function of the endocytic machinery can
inhibit APP internalization, and shift APP proteolysis to a
non-amyloidogenic pathway, in HEK cells. In HeLa cells,
in contrast, an interfering dynamin mutant increased both
α-secretase cleavage of APP and Aβ formation [20], sug-
gesting that cell-specific differences in APP metabolism
may influence the consequences of altered endocytosis.
The levels of a number of proteins important for clathrin-BMC Cell Biology 2005, 6:30 http://www.biomedcentral.com/1471-2121/6/30
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mediated recycling of synaptic vesicles, including
dynamin, and the clathrin assembly-mediating adapter
proteins AP2 and AP180, are reduced in the brains of AD
patients [45]. Moreover, exposure of neurons to Aβ in
vitro was recently reported to reduce dynamin levels [46].
It is therefore possible that alterations in clathrin-medi-
ated endocytosis play a role in the abnormal metabolism
of APP that is characteristic of AD. Finally, given the puta-
tive role of APP as a cell surface signaling molecule in the
brain [47], it is important to consider the possibility that
alterations in APP endocytosis may contribute to the path-
ologic process by disrupting the normal signaling func-
tion of APP.
Methods
Materials
Antibodies and other reagents were obtained from the fol-
lowing sources: 6E10 antibodies to sAPPα from Signet
Laboratories (Dedham, MA), antibodies to the C-termi-
nus of APP (APP-CT) from Zymed Labs (San Francisco,
CA), anti-dynamin monoclonal antibodies from BD Bio-
sciences (San Diego, CA), goat polyclonal antibodies spe-
cific for dynamin I from Santa Cruz Biotechnology (Santa
Cruz, CA), and goat anti-mouse IgG and goat anti-rabbit
IgG peroxidase-conjugated secondary antibodies from
BioRad (Hercules CA). Immunofluorescence-conjugated
secondary antibodies including Alexa Fluor 488-conju-
gated goat or donkey anti-mouse IgG, and Alexa Fluor
594-conjugated rabbit anti-goat IgG, and ProLong Anti-
fade mounting medium were obtained from Molecular
Probes (Eugene, OR). Mini-gels and reagents for electro-
phoresis were obtained from BioRad (Hercules CA), and
polyvinylidene difluoride (PVDF) membranes were pur-
chased from Perkin-Elmer (Boston, MA). The metallopro-
teinase inhibitor, tumor necrosis factor-α protease
inhibitor (TAPI-1), was obtained from Peptides Interna-
tional (Louisville, KY). 2-Mercaptoethanesulfonic acid
sodium salt, iodoacetamide, and phorbol 12-myristate
13-acetate (PMA) were obtained from Sigma-Aldrich (St.
Louis MO). Sulfo-NHS-SS-Biotin was purchased from
Pierce (Rockford, IL), Other reagents and materials were
acquired from Fisher Scientific (Pittsburgh PA).
Cell culture
HEK-M3 cells (HEK cells stably transfected with M3 mus-
carinic receptors) and HEK-695 cells (HEK cells stably
overexpressing APP695; a gift from Dr. Dennis Selkoe)
were grown in Dulbecco's Modified Eagle Medium
(DMEM)/F-12 supplemented with 10% Fetal Bovine
Serum (Invitrogen Life Technologies, Carlsbad, CA) and
maintained at 37°C in an atmosphere of 95% air, 5%
CO2. HEK-M3 cells were used in some of these studies
because the regulation of constitutive and receptor-cou-
pled sAPPα release has been well characterized in this line
[5,48,49].
Transient transfections
Cells were transiently transfected with plasmids encoding
APP695 (a gift from Dr. Carmela Abraham) and dyn I K44A
(a gift from Dr. Marc Caron), or with an empty pcDNA3
vector, using Lipofectamine Plus™ reagent (Invitrogen Life
Technologies, Carlsbad CA) according to the manufac-
turer's specifications. Experiments were carried out 48
hours later.
Cell surface biotinylation
Confluent HEK cells were pre-incubated in serum-free
DMEM for 2 hours, then washed in phosphate buffered
saline (PBS), pH 7.9, supplemented with 1 mM Ca++ and
2 mM Mg++. Surface biotinylation was carried out by incu-
bating the cells for 30 min on ice with Sulfo-NHS-SS-
Biotin (0.5 mg/ml in PBS). Culture dishes were kept on ice
in the dark and gently rocked during the incubation
period. The biotin reagent was quenched by treating the
cells with two 15 min washes of 50 mM glycine in PBS.
Cells were rinsed again with PBS and lysed in a buffer con-
taining 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 2 mM
4-(2-aminoethyl)benzenesulfonyl fluoride, 1 µg/ml leu-
peptin, 1% (v/v) Nonidet P-40, 0.05% (w/v) sodium
dodecyl sulfate, 0.5% (w/v) deoxycholate. Lysates were
incubated overnight with streptavidin-coated agarose
beads (Pierce, Rockford, IL) at 4°C in a rotary mixer to
isolate biotin-labeled proteins. Isolates were size-fraction-
ated on SDS gels, and analyzed for APP content by
immunoblotting.
Reversible biotinylation
HEK cells were pre-treated for 1 hour at 37°C in serum-
free DMEM containing TAPI-1 (50 µM), then surface-
biotinylated as described above. Cells were then incu-
bated at 37° for various time periods in the presence of
TAPI-1 and either PMA (1 µM) or DMSO (vehicle con-
trol). The cells were placed on ice and the remaining sur-
face biotin was removed by applying two 20 minute
washes of a stripping buffer (50 mM 2-mercap-
toethanesulfonic acid (sodium salt); 150 mM NaCl; 1 mM
EDTA and 0.2% BSA in 20 mM Tris, pH 8.6). The 2-mer-
captoethanesulfonic acid was quenched with a buffer con-
taining iodoacetamide (50 mM iodoacetamide, 1% BSA
in PBS, pH 7.4) for 30 minutes, and cells were rinsed with
PBS. To assess the efficiency of the stripping procedure,
some cultures were biotinylated and then stripped while
remaining on ice.
Western blotting
The protein content of cell lysates was measured using the
bicinchoninic acid reagent (Sigma, St Louis MO).
Medium was collected, cleared by centrifugation,
desalted, lyophilized, and resuspended in SDS-PAGE
loading buffer, as previously described [5]. Lysates were
centrifuged to remove insoluble material, and diluted inBMC Cell Biology 2005, 6:30 http://www.biomedcentral.com/1471-2121/6/30
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2X loading buffer. Samples were normalized for protein
content and size-fractionated on 7.5% or 10–20% Tris-
HCl mini-gels. Proteins were transferred to PVDF mem-
branes, which were then blocked in 5%-powdered milk in
Tris-buffered saline with 0.15% Tween-20 for 2 hours,
and probed overnight with primary antibodies. The next
day, membranes were washed, and incubated with goat
anti-mouse IgG or goat anti-rabbit IgG peroxidase-conju-
gated secondary antibodies and bands were detected
using an enhanced chemiluminescence reagent (Western
Lightning, Pierce). Membranes were imaged on a Kodak
440CF Image Station and quantitated using Kodak 1D
Image Analysis software.
Immunofluorescence microscopy
Cells were plated on nitric acid-washed coverslips coated
with poly-D-lysine and placed in 30-mm tissue culture
dishes. After 48 hours in growth medium, live cells were
washed with PBS, and incubated on ice with 6E10 anti-
bodies (at a dilution of 1:200 in PBS) to label surface APP.
Cells were then transferred to an incubator and main-
tained at 37°C for various time periods. Cells were fixed
in 3.0% paraformaldehyde in PBS for 10 minutes at room
temperature, permeabilized in 0.1% Triton X-100, and
blocked in 1% bovine serum albumin in PBS. APP was
detected by incubating the cells with goat anti-mouse
antibodies conjugated with Alexa Fluor 488. When dou-
ble-labeling of APP and dynamin was required, cell prep-
arations were incubated with goat anti-dynamin I primary
antibodies (1:400), washed, then incubated with donkey
Alexa Fluor 488-conjugated anti-mouse IgG, and rabbit
Alexa Fluor 594-conjugated anti-goat IgG (1:200). After
washing in PBS, cells were mounted with ProLong Anti-
Fade mounting medium and left overnight to dry. Speci-
mens were examined using a conventional fluorescence
microscope equipped with appropriate band-pass filters,
and images were captured with a Spot RT-KE camera
(Diagnostics Instruments, Sterling Heights MI).
Aβ measurement
HEK-695 cells were plated and transiently transfected
with dyn I K44A or with empty vector, as described above,
and allowed to grow for 48 hours. The growth medium
was removed, and the cells were rinsed with serum-free
DMEM. Fresh DMEM was then placed on the cells and
they were incubated overnight. The next day, the medium
was collected and a 1 ml aliquot was analyzed by enzyme-
linked immunosorbent assay (ELISA) using a kit from Sig-
net Laboratories (Dedham MA). Standards and samples
were prepared and incubated in the plate overnight at
4°C. The ELISA was performed the next day according to
the manufacturer's instructions.
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